Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes STAAR Surgical Company (NASDAQ: STAA). He doesn't understand why it's not bought by someone.
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
Danimer Scientific (NYSE:DNMR) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $(0.07) by 657.14 percent. The company reported quarterly sales of $14.50 million which beat the
Companies Reporting Before The Bell
• Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter.
• Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.